PubMed:22574726 / 0-177 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T1","span":{"begin":0,"end":175},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":175},"obj":"Sentence"}],"text":"Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals.\nS"}

{"project":"sentences","denotations":[{"id":"T1","span":{"begin":0,"end":175},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":175},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals.\nS"}

{"project":"Glycosmos6-MAT","denotations":[{"id":"T1","span":{"begin":57,"end":62},"obj":"http://purl.obolibrary.org/obo/MAT_0000058"}],"text":"Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals.\nS"}

{"project":"Anatomy-MAT","denotations":[{"id":"T1","span":{"begin":57,"end":62},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000058"}],"text":"Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals.\nS"}

{"project":"HP-phenotype","denotations":[{"id":"T1","span":{"begin":124,"end":150},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0002037"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals.\nS"}

{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":124,"end":150},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005265"}],"text":"Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals.\nS"}

{"project":"Anatomy-UBERON","denotations":[{"id":"T1","span":{"begin":45,"end":51},"obj":"Body_part"},{"id":"T2","span":{"begin":57,"end":62},"obj":"Body_part"},{"id":"T3","span":{"begin":137,"end":142},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0001088"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000160"}],"text":"Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals.\nS"}